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ing Treatment of Abdominal Aortic Aneurysms: A Systematic Review
Marlow N.E., Barraclough B., Collier N.A., Dickinson I.C., Fawcett J.,
Graham J.C., Maddern G.J. Eur J Vasc Endovasc Surg 2010;40:572-9.
Objectives: This systematic review assessed the efficacy of centralisa-
tion for the treatment of unruptured and ruptured abdominal aortic aneu-
rysms. Patient outcomes achieved by low and high volume hospitals/
surgeons, including morbidity, mortality and length of hospital stay, were
used as proxy measures of efficacy.
Design: Systematic review was designed to identify, assess and report
on peer-reviewed articles reporting outcomes from unruptured and rup-
tured abdominal aortic aneurysms. No language restriction was placed on
the databases searched.
Materials: Only peer-reviewed journals articles were included.
Methods: To ensure the contemporary nature of this review, only
studies published between January 1997 and June 2007 were sought.
Studies were included if they reported on at least one volume type and
patient outcome.
Results: Twenty two studies were included in this review. In the
majority of group assessments, the number of studies reporting statistical
significance was similar to the number of studies reporting no statistical
significance.
Conclusion: The paucity of studies reporting statistically significant
results demonstrates that although this evidence exists, its potential to be
overstated must also be taken into account when drawing conclusions as to
its efficacy for twenty first century healthcare systems.
Open Repair for Ruptured Abdominal Aortic Aneurysm and the Risk
of Spinal Cord Ischemia: Review of the Literature and Risk-factor
Analysis
Peppelenbosch A.G., Vermeulen Windsant I.C., Jacobs M.J., Tordoir
J.H.M., Schurink G.W.H. Eur J Vasc Endovasc Surg 2010;40:589-95.
Objectives: Spinal cord ischemia after open surgical repair for rAAA is
a rare event. We estimated the current incidence and tried to identify risk
factors. We also report a new case.
Methods: Group A consisted of 10 reports on open repair for rAAA
from 1980 until 2009. Only series of 100 patients were considered to
estimate the incidence. Thirty three case reports from 1956 until 2009 were
identified (group B). Case reports from group B were not encountered in
group A. Group B patients were stratified according to the type of neuro-
logical deficit as described by Gloviczki (type I complete infarction and type
II infarction of the anterior two third).
Results: Group A consisted of 1438 patients. In group A 86% were
male with a mean age of 72.1 years. The incidence of post-operative
paraplegia was 1.2% (range 0–2.8%). In-hospital mortality was 46.9%.Of the
33 patients of group B were 86% male with a mean age of 68.0 years. Most
patients developed a type I (42%) or type II (33%) deficit. In-hospital
mortality was 51.6%. No significant differences between different types were
encountered.
Conclusion: Spinal cord ischemia after ruptured AAA is a rare compli-
cation with an incidence of 1.2% (range 0–2.8%).
Quality of Life Among Lower Extremity Peripheral Arterial Disease
Patients who have Undergone Endovascular or Surgical Revasculariza-
tion: A Case-control Study
Remes L., Isoaho R., Vahlberg T., Viitanen M., Rautava P. Eur J Vasc
Endovasc Surg 2010;40:618-25.
Objectives: To assess the quality of life (QoL) of peripheral arterial
disease (PAD) patients who have undergone either percutaneous translumi-
nal angioplasty (PTA) only and/or one or more surgical revascularizations.
Design: A postal questionnaire study in which a case-control method-
ology was applied.
Materials and methods: 131 patients with PTAs (mean age 70.7, SD
10.4 yrs; range 39–89, 58% men) and 100 with surgical revascularizations
(mean age 67.8, SD 10.4 yrs; range 43–91, 62% men), in 1998–2003, and
their age- and gender-matched controls were studied. The mean time since
the last revascularization for PTA was 2.7, SD 1.3 yrs and for operatedpatients 3.5, SD 1.8 yrs. Ankle–brachial pressure index (ABI) and Mini-
Mental-State Examination (MMSE) score were obtained from 70% of the
patients.
QoLwas assessed using 15DHealth-relatedQoL instrument, Rand-36
Physical Functioning subscale, 6-item Brief Social Support Questionnaire,
Geriatric Depression Scale (GDS), Self-reported Life Satisfaction (LS) score,
and one ‘perceived state of health’ question.
Results: Patients after endovascular and/or surgical revascularization
(most with ABIs 0.5–0.89 and without cognitive impairment), had similarly
lower QoL, GDS and LS indicated more depression than their controls.
Conclusion: Poor QoL and depression should be thoroughly consid-
ered, alongside proper follow-up and ABI-measurements.
Upper-Limb Thrombo-Embolectomy: National Cohort Study in
Denmark
Andersen L.V., Mortensen L.S., Lindholt J.S., Faergeman O., Henneberg
E.W., Frost L. Eur J Vasc Endovasc Surg 2010;40:628-34.
Objectives: We investigated the incidence of thrombo-embolectomy
in upper-limb and prognosis with respect to arm amputation, stroke and
death.
Methods: We performed a national cohort study of individuals, aged
40–99 years, and undergoing first-time thrombo-embolectomy in the bra-
chial, ulnar or radial artery in Denmark from 1990 to 2002. The data were
retrieved from the National Vascular Registry and from the National Regis-
try of Patients and the Civil Registration System. Patients were followed
until 2006 to ascertain the occurrence of amputation and stroke and until
2007 with respect to death.
Results: In total, 1377 incident cases of thrombo-embolectomy were
registered, comprising 504 (36.6%) males with a mean age of 72.0 (standard
deviation (SD) 12.4) years and 873 (63.4%) females with a mean age of 77.2
(SD 11.7) years. Incidence was 3.3 (95% confidence interval (CI): 3.1–3.7)
for males and 5.2 (95% CI: 4.9–5.6) for females per 100000 person-years.
After thrombo-embolectomy, upper-limb amputation was performed in 11
(incidence 2.2%; 95% CI: 1.2–3.4) males and 31 (3.6%; 95% CI: 2.5–4.9)
females. Age- and sex-specific risk of stroke was 2–16 times higher, and risk
of death 3–11 times higher, than in the general population.
Conclusions: Upper-limb thrombo-embolectomy is associated with
an increased risk of limb amputation, stroke and death.
Randomised Controlled Trial Comparing Sapheno-Femoral Ligation
and Stripping of the Great Saphenous Vein with Endovenous Laser
Ablation (980 nm) Using Local Tumescent Anaesthesia: One Year
Results
Pronk P., Gauw S.A., Mooij M.C., Gaastra M.T.W., Lawson J.A., van
Vlijmen-van Keulen C.J. Eur J Vasc Endovasc Surg 2010;40:649-56.
Objectives: Comparison of sapheno-femoral ligation and stripping
(SFL/S) versus endovenous laser ablation (EVLA, 980-nm) in the treat-
ment of great saphenous vein (GSV) insufficiency, using local tumescent
anaesthesia.
Design: Randomised, single centre trial.
Materials and methods: Patients with GSV incompetence and vari-
cose veins were randomised to either SFL/S or EVLA. At days 1, 2, 3, 7, 10,
and 14 post-treatment, patients completed questionnaires on pain and
quality of life. Recurrent varicose veins were evaluated by Duplex ultrasound
(DUS) performed at 1 and 6 weeks, and 6 and 12 months.
Results: 130 legs in 121 patients were treated by SFL/S (n  68) or
EVLA (n  62). Significantly more post-treatment pain was noted after
EVLA at days 7, 10 and 14 (p  0.01; p  0.01; p  0.01), more hindrance
in mobility at days 7 (p  0.01) and 10 (p  0.01), and in self care
(p  0.03) and daily activities (p  0.01) at day 7 compared to SFL/S. DUS
at 1-year follow-up showed 9% recurrences (5/56) after EVLA and 10%
(5/49) after SFL/S.
Conclusion: Both SFL/S and EVLA, using local tumescent anaesthe-
sia, were well tolerated, with no difference in short-term recurrence rate. In
the second week after EVLA, patients experienced significantly more pain
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